Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

Year
2024
Data d'inici
Data de tancament
Descripció
Study coordinator-Research Group on Status Epilepticus and Acute Seizures_20240172
Codi
2024-172
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Research Technician Pediatric Cardiology Group_20240173
Codi
2024-173
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Project Manager for Advanced Therapies & Rare Diseases_20240169
Codi
2024-169
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Project Manager for Internal Strategy Area_20240170
Codi
2024-170
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Post-Award National Project Manager_20240168
Codi
2024-168
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
IT Product Owner_20240167
Codi
2024-167
Reclutant
Inactiu

Professionals

Anna Jeanne Behr

Professionals

Marc Tort Lacambra

Professionals

Eddie Pradas Gracia

Professionals

Roger Rica Peiro

Year
2024
Data d'inici
Data de tancament
Descripció
Administrative Accountant_20240165
Codi
2024-165
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Pediatric Oncology Nutritionist_20240166
Codi
2024-166
Reclutant
Inactiu

Estudio de fase 3 multicéntrico, de etiqueta abierta para evaluar la eficacia, farmacocinética, seguridad e inmunogenicidad del ustekinumab administrado porvía subcutánea en participantes pediátricos con artritis psoriásica juvenil activa(PSUMMIT Jr)

  • Protocol code: CNTO1275JPA3001
  • EudraCT code: 2020-005503-40
  • Principal investigator:  Lopez Corbeto, Mireia
  • Research group:  Reumatologia
  • Service: Reumatologia
  • Phase: Fase III
  • Recruiting: Open
  • Status: Iniciat

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.